DLA PharmaceuticalsTypically replies within 1 hour

DLA Pharmaceuticals is a dynamic and research-driven pharmaceutical company dedicated to advancing scientific discovery by providing high-quality, research-grade products.
Our mission is to support scientists, academic institutions, and biotech industries with reliable tools that enable breakthrough innovations in medicine, biotechnology, and life sciences.

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Loading...

© 2025 DLA Pharmaceuticals. All rights reserved.

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

CoV-2 S1 (319-541), Sf9 | DLA Pharmaceuticals

Enzymes and ProteinProtein

CoV-2 S1 (319-541), Sf9

CAT Number

DLA/SARS/35834

Unit Size

As Required

Updated

March 10, 2026

Product Description

Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), SF9

Protein

Interested in this product?

Contact our team for pricing, availability, and technical support.

Browse More Products